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Female fertility declines with increasing age. It has been 
thought that the decline of female fertility is caused by 
the loss of follicles/oocytes in ovary; however, several 
reports indicate that about 10,000 follicles are present in 
ovary of women over 40 years of age [1]. In the women 
over 40 years of age, irregular menstrual cycles are 
related to abnormal endocrine profiles (high FSH/high 
LH/low AMH) [2]. Exogenous hormone treatment does 
not rescue the ovarian function in these women and 
predicts a low number of matured oocyte with poor 
quality in assisted reproductive technology (ART). In 
mice, around 10 months of age, the ovary contains a 
large number of small follicles. However, the female 
mice exhibit an extended estrous phase and a poor 
response to standard super-ovulatory regimens, sug-
gesting that the decline in fertility of aged women and 
mice is related not only to the loss of follicles in ovary 
but also to the changes of ovarian function. In our 
previous studies [3], granulosa cell-specific Nrg1 
knockout (KO) mice (gcNrg1KO) exhibited longer 
estrous cycles and a reduced number of pups born, with 
a linear decline from 6-10 months of age. To determine 
whether the mutant mice represent a model of ovarian 
aging, markers of ovarian aging were analyzed in 
ovaries of 6-month-old gcNrg1KO mice. The mutant 
mice exhibit premature signs of ovarian aging that are 
observed in older WT mice and women, including a 
reduced response to exogenous hormonal treatment; 
elevated serum levels of LH, FSH, and testosterone; and 
reduced levels of inhibin B and AMH, that is a marker 
of the ovarian reserve. Therefore, we analyzed the 
mechanisms that contribute to reduced ovarian function 
with increasing age using gcNrg1KO mice as a model 
of ovarian aging. 
In the ovaries of 6-month-old gcNrg1KO mice, 
follicular development was blocked in bilayer seconda-
ry follicles and heterogeneous cells accumulated in the 
ovarian stroma. Immunohistochemical analysis and 
picrosirius red staining, that visualizes collagen in 
paraffin-embedded tissue sections, showed that the 
heterogeneous cells in ovarian stroma were distin-
guished as two different types: LH receptor-positive 
endocrine cells (Figure 1A), and actin-rich fibrotic cells 
expressing collagen (Figure 1B). This ovarian 
phenotype was also observed in 12-month-old WT 
mice, suggesting that the endocrine and fertility changes 
that occur with increasing  age  are  associated  with  the 
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aberrant accumulation of endocrine cells in the ovarian 
stroma and their high expression of Cyp17a1, Cyp19a1, 
and Lhcgr. The accumulation of endocrine cells in the 
ovarian stroma has previously been observed in ovaries 
of LH beta (LHβ) over-expressing mice with increasing 
age [4]. Additionally, the fibrosis in the ovarian stroma 
and increased levels of basal LH are also observed in 
the patients with hyper-secretion of LH [5]. Based on 
these considerations, we hypothesized that the accumu-
lation and function of these cells appeared to be driven 
by elevated LH, and that the fibrosis suppressed 
follicular development. To analyze this hypothesis, 6-
month-old gcNrg1KO and 12-month-old WT mice were 
treated for 8-days with a GnRH-antagonist; ovarian 
histology showed that this regimen caused both the 
aberrant endocrine cells and fibrotic cells to disappear.  
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Figure  1.  The  morphological  changes  in  the ovary  with
increasing age. (A)  The localization of the heterogeneous, CYP19‐
positive,  CYP17‐positive,  and  LHR‐positive  cells  in  ovaries  of  6‐
month‐old gcNrg1KO mice. Scale bars correspond to 300 µm (×100).
(B)  The images stained using rhodamine phalloidin, that is a marker
of F‐actin, and DAPI with constant settings that were established for
the 12‐month old gcNrg1KO. Scale bars in image are 300 µm. 
Moreover, by 4 days after final GnRH treatment, 
follicular development had proceeded to the antral 
stages. The treated mice regained normal, recurrent 
estrous cycles and continuously delivered pups for at 
least for 3 months, suggesting that LH-induced fibrosis 
in the ovarian stroma appears to alter the follicular-
stroma microenvironment and restricts follicle growth at 
the secondary stage. Recently, Kawamura et al. [6] 
reported that the growth of secondary follicles to the 
multilayer stage in ovaries of low FSH-responding 
women was induced by the physical stimulation (cutting 
ovary) in vivo. They successfully promoted follicle 
growth and performed in vitro fertilization, and a 
healthy baby was delivered. The mechanisms by which 
mechanical stress appears to suppress follicle growth 
were explained by the YAP/TAZ mechano-transduction 
system in granulosa cells [7]. However, in the present 
study, the strong intensity of F-actin was only observed 
in the ovarian stroma and not within follicles. 
Therefore, further studies are required to determine the 
relationships among the abnormal endocrine condition, 
the accumulation of fibrotic tissue in ovarian stroma, 
and the suppression of follicular development in pre-
antral follicles.  
In conclusion, the appearance and maintenance of the 
aberrant endocrine cells and fibrous tissue within the 
ovarian stroma are dependent on chronic high levels of 
LH with increasing age. The accumulation of these cells 
and tissue in the ovarian stroma appears to impact 
surrounding secondary follicles leading to impaired 
follicular development by an FSH-independent manner. 
That long-term GnRH antagonist treatment normalized 
the endocrine functions and matrix conditions of the 
ovary and improved the fertility documents that the 
ovarian defects are LH-dependent. Thus, GnRH 
antagonist treatments might provide a new, noninvasive 
strategy for improving fertility in a subset of aging 
women before menopause. 
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